Home > Insider Trading > Filing (0001209191-12-019446)

Filing Details

Accession Number:: 0001209191-12-019446
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-03-21 19:02:17
Reporting Period:: 2012-03-19

Filing Date:: 2012-03-21
Accepted Time:: 2012-03-21 19:02:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1021412	W Jack Schuler	10165 Mckellar Court San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-03-19	10,000	$16.60	3,255,650	No	4	P	Direct
Common Stock	Acquisiton	2012-03-20	15,815	$16.48	3,271,465	No	4	P	Direct
Common Stock	Acquisiton	2012-03-21	40,000	$16.65	3,311,465	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The shares reported on this Form 4 were purchased by the Jack W. Schuler Living Trust.
The weighted average purchase price for these transactions was $16.5954 per share, with a range of $16.55 to $16.60 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
In addition to the shares reported on this Form 4 as directly owned by the Reporting Person, 65,000 shares are held indirectly by the Reporting's spouse, 441,961 shares are held indirectly by the Schuler Family Foundation, and 683,843 shares are held indirectly by trusts for the benefit of the Reporting Person's children. The Reporting Person disclaims all beneficial ownership of the shares owned by his spouse and the trusts for the benefit of his children, except to the extent of his pecuniary interest, if any.
The weighted average purchase price for these transactions was $16.4766 per share, with a range of $16.41 to $16.51 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
The weighted average purchase price for these transactions was $16.6482 per share, with a range of $16.465 to $16.75 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.